BIOLIFE SOLUTIONS INC (BLFS)
US09062W2044 - Common Stock
BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services...
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing...
Notable earnings after Thursday's close
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
Commit To Purchase Biolife Solutions At $12.50, Earn 11% Annualized Using Options
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services...
Biolife Solutions Breaks Above 200-Day Moving Average - Bullish for BLFS
BioLife Solutions files to sell 927.2K shares for holders (NASDAQ:BLFS)
Biotech company BioLife Solutions files prospectus for resale of 927.2K common shares; prospectus clarified not to be considered as an offer to sell...
BioLife Solutions GAAP EPS of -$0.67 misses by $0.29, revenue of $33.3M in-line (NASDAQ:BLFS)
BioLife Solutions press release (NASDAQ:BLFS): Q3 GAAP EPS of -$0.67 misses by $0.29.Revenue of $33.3M (-18.2% Y/Y) in-line.Continues to expect its full...
BioLife Solutions Reports Third Quarter 2023 Financial Results
/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing...
BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies...
Commit To Purchase Biolife Solutions At $7.50, Earn 19.8% Annualized Using Options
BioLife Solutions says Casdin Partners Master Fund buys 927.2K shares in co (NASDAQ:BLFS)
Casdin Partners Master Fund buys 927.2K shares of BioLife Solutions (BLFS) at $11.19 per share.
BioLife Solutions expects FY revenue at low end of guidance, names new CEO; shares fall
BioLife Solutions expects its 2023 revenue at the low end of its forecast, with preliminary Q3 revenue of $33.3 million. Read more.
Why Shares of BioLife Solutions Plummeted This Week
The company saw revenue decline, year over year, in the second quarter.
Why Shares of BioLife Solutions Are Slumping on Wednesday
The company reported declining revenue and reduced annual guidance.
BioLife Solutions GAAP EPS of -$0.23 misses by $0.02, revenue of $39.51M misses by $3.82M (NASDAQ:BLFS)
BioLife Solutions press release (BLFS): Q2 GAAP EPS of -$0.23 misses by $0.02.Revenue of $39.51M (-2.4% Y/Y) misses by $3.82M.Total revenue for the second quarter of 2023 was...
BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business
/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of class-defining bioproduction tools and services for...
Commit To Buy Biolife Solutions At $15, Earn 12% Annualized Using Options
BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies...
Biolife Solutions (BLFS) Shares Cross Below 200 DMA
BioLife Solutions Launches the IntelliRate™ i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products...
Biolife Solutions Breaks Above 200-Day Moving Average - Bullish for BLFS
BioLife Solutions GAAP EPS of -$0.32 misses by $0.11, revenue of $37.7M misses by $5.24M (NASDAQ:BLFS)
BioLife Solutions press release (BLFS): Q1 GAAP EPS of -$0.32 misses by $0.11.Revenue of $37.7M (+4.1% Y/Y) misses by $5.24M.We remain confident that we will achieve Q4 2024 run...
BioLife Solutions Reports First Quarter 2023 Financial Results
/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products...
BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023
/PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies...